Challenges to diagnosis of HIV-associated wasting

Journal of Acquired Immune Deficiency Syndromes

Volumn 37, Issue SUPPL. 5, 2004, Pages

  Kotler, Donald ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Body cell mass; Body composition; HIV complications; HIV wasting; Metabolic abnormalities; Protein energy malnutrition

Indexed keywords

CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; WASTING SYNDROME; WEIGHT REDUCTION;

BODY COMPOSITION; ELECTRIC IMPEDANCE; HIV WASTING SYNDROME; HUMANS;

EID: 10044256366     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000144383.55091.c1     Document Type: Conference Paper

References (24)

1. Serwadda D, Mugerwa RD, Sewankambo NK, et al. Slim disease: a new disease in Uganda and its association with HTLV-III infection. Lancet. 1985;ii:849-852.
2. Kotler DP, Tierney AR, Wang J, et al. Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 1989;50:444-447.
3. Dupont HL, Marshall GD. HIV-assoctated diarrhoea and wasting. Lancet. 1995;346:352-356.
4. Nolan D, Hammond E, James I, et al. Contribution of nucleoside-analogue reverse transcriptase inhibitor therapy to lipoatrophy from the population to the cellular level. Antivir Ther. 2003;8:617-626.
5. Centers for Disease Control. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR Morb Mortal Wkly Rep. 1987;36:3S-15S.
6. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDS. 2001;15:411-423.
7. Lelli G, Montanari M, Gilli G, et al. Treatment of the cancer anorexiacachexia syndrome: a critical reappraisal. J Chemother. 2003;15:220-225.
8. Nelson KA, Walsh D, Sheehan FA. The cancer anorexia-cachexia syndrome. J Clin Oncol. 1994;12:213-225.
9. Moore FD, Boyden CM. Body cell mass and limits of hydration of the fat-free body: their relation to estimated skeletal weight. Ann NY Acad Sci. 1963;110:62-71.
10. Jebb SA, Elia M. Techniques for the measurement of body composition: a practical guide. Int J Obes Relat Metab Disord. 1993;17:611-621.
11. Schwenk A, Beisenherz A, Kremer G, et al. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr. 1999;70:867-873.
12. Wanke CA, Silva M. Knox TA, et al. Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
13. Wheeler DA, Gibert CL, Launer CA, et al. Weight loss as a predictor of survival and disease progression in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18:80-85.
14. Paton NI, Macallan DC, Jebb SA, et al. Longitudinal changes in body composition measured with a variety of methods in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:119-127.
15. Macallan DC, Noble C, Baldwin C, et al. Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med. 1995;333:83-88.
16. Kotler DP, Rosenbaum K, Allison DB, et al. Validation of bioimpedance analysis as a measure of change in body cell mass as estimated by wholebody counting of potassium in adults. J Parenter Enteral Nutr. 1999;6:345-349.
17. Kotler DP, Tierney AR, Dilmanian FA, et al. Correlation between total body potassium and total body nitrogen in patients with acquired immunodeficiency syndrome. Clin Res. 1991;39:649A.
18. Kyle UG, Genton L, Gremion G, et al. Aging, physical activity, and height-normalized body composition parameters. Clin Nutr. 2004;23:79-88.
19. Mulligan K, Tai VW, Schambelan M. Cross-sectional and longitudinal evaluation of body composition in men with HIV infection. J Acquir Immune Defic Syndr. 1997;15:43-48.
20. Silva M, Skolnik PR, Gorbach SL, et al. The effect of protease inhibitors on weight and body composition in HIV-infected patients. AIDS. 1998;12:1645-1651.
21. Galli M, Veglia F, Angarano G, et al. Gender differences in antiretroviral drug-related adipose tissue alterations: women are at higher risk than men and develop particular lipodystrophy patterns. J Acquir Immune Defic Syndr. 2003;34:58-61.
22. Engleson ES, Tierney AR, Pi-Sunyer FX, et al. Effects of megestrol acetate on body composition and circulating testosterone in patients with AIDS. J Acquir Immune Defic Syndr. 1995;9:1107-1108.
23. Kotler DP, Fogleman L, Tierney AR. Comparison of total parenteral nutrition and oral, elemental diet upon body composition and quality of life in AIDS patients with malabsorption. J Parenter Enteral Nutr. 1998;22:120-126.
24. Tang AM, Forrester J, Spiegelman D, et al. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:230-236.